169307 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids; General methods of protein analysis not limited to specific proteins or families of proteins; Determination of free amino acids Assays for specific amino acids
Biomarkers for prostate cancer and methods using the same
#302Methods and compositions for multiplexed screening of disease
#303Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#304Diagnosis of conditions associated with decreased arginine bioavailability
#305TYROSINE PHOSPHORYLATION SITES
#306Luminescence assay using macrocyclic lanthanide (III) complexes
#307Use of arylboronic acids in protein labelling
#308COMPOSITIONS AND METHODS FOR TISSUE-BASED PROTEIN TRUNCATION TEST FOR DISEASE DIAGNOSIS
#309Methods for detecting symmetrical dimethylarginine
#310Methods for Detecting Asymmetric Dimethylarginine in a Biological Sample
#311Methods of treatment using ammonia-scavenging drugs
#312Analysis of amino acid copolymer compositions
#313METABOLIC SYNDROME EVALUATING APPARATUS, METHOD, SYSTEM, PROGRAM, AND RECORDING MEDIUM THEREFOR
#314Stress evaluating apparatus, method, system and program and recording medium therefor
#315TREATMENT OF DNA DAMAGE RELATED DISORDERS
#316ASSAY FOR MEASURING ASYMMETRIC METHYLARGININE IN A BIOLOGICAL SAMPLE
#317Methods and Compositions Comprising Non-Natural Amino Acids
#318Binding compounds, immunogenic compounds and peptidomimetics
#319Detecting isomers using differential derivatization mass spectrometry
#320PROPIONYL AND BUTYRYL LYSINE MODIFICATIONS IN PROTEINS
#321Method of assaying glycated protein
#322Methods of assessing the need for and the effectiveness of therapy with antioxidants
#323Method for determining the concentration of asymmetric dimethylarginine (ADMA)
#324Hepatic disease-evaluating apparatus, hepatic disease-evaluating method, hepatic disease-evaluating system, hepatic disease-evaluating program and recording medium
#325Mass Spectrometry of Arginine-Containing Peptides
#326Measuring thyroxine levels from dried blood samples using mass spectrometry
#327Distinguishing Isomers Using Mass Spectrometry
#328ATM KINASE COMPOSITIONS AND METHODS
#329Screening for neurotoxic amino acid associated with neurological disorders
#330O-acetyltranferases
#331Screening for neurotoxic amino acid associated with neurological disorders
#332Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid
#333Biomarker of improved intestinal function
#334Method for quantitative and semi-quantitative detection of l-phenylalanine, l-tyrosine, l-3,4-dihydroxyphenylalanine and their corresponding keto-acids, phenylpiruvic acid, 3-hydroxyphenylpyruvic acid and 3,4-dihydroxyphenylpyruvic acid in biological fluids, related kits for diagnosis and monitoring of altered metabolisms of these aminoacids
#335Method of determining substrate contained in hemoglobin-containing sample
#336Medical device for monitoring blood phenylalanine levels
#337Method for the selective isolation of multiply-charged peptides applicable in the quantitative proteomics
#338Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#339Diagnostic methods for determining susceptibility to convulsive conditions
#340Method of analyzing protein and kit for analyzing protein
#341Analysis of molecules
#342ATM kinase compositions and methods
#343Immunoassay of phosphorylated proteins
#344Simultaneous detection of metabolic enzyme activity and metabolite levels
#345Treatment of DNA damage related disorders
#346Selective binding and analysis of macromolecules
#347Detection of post-translationally modified analytes
#348Method for determination of likelihood of occurrence of preterm labor in pregnant females
#349Diagnosis of conditions associated with decreased arginine bioavailability
#350Specific epitope based immunological diagnosis of tuberculosis
#351Method for determination of arginine, methylated arginines and derivatives thereof
#352Methods of determining deficiencies in intracellular levels on cysteine and glutathione
#353Methods of detecting nitrotyrosine and aminotyrosine residues of peptides and proteins
#354Diagnostic methods for determining susceptibility to convulsive conditions
#355Mass spectrometry-based identification of proteins
#356Identification of modified peptides by mass spectrometry
#357Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
#358Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#359Methods of assessing the need for and the effectiveness of therapy with antioxidants
#360Method of examining and diagnosing integration dysfunction syndrome
#361Method and system for rapid biomolecular recognition of amino acids and protein sequencing
#362Method for quantitatively determining homocysteine and a reagent for quantitative determination of homocysteine
#363ATM kinase compositions and methods
#364Diagnostic methods for asthma
#365Treatment of dna damage related disorders
#366Quantification and site-specific profiling of protein phosphorylation
#367Screening for neurotoxic amino acid associated with neurological disorders
#368Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#369Treatment of DNA damage related disorders
#370Treatment of radiation disorders
#371Method of isolating and analyzing oligosaccharides in glycoproteins